Annenberg Center for Health Sciences
Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM
Explorez les avancées de la recherche sur la myasthénie grave, en mettant l'accent sur l'amélioration de la qualité de vie des patients et les limites des traitements par des experts.
Wrap Up
2 mins • Nov 19, 2024
Charts
This show is not currently ranked in any charts.
Épisodes récents

Nov 19, 2024
Wrap Up
2 mins

Nov 19, 2024
Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT
3 mins

Nov 19, 2024
Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study
3 mins

Nov 19, 2024
Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results
3 mins

Nov 19, 2024
Cyclic and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis Part A of ADAPT NXT
3 mins

Langue
Anglais
Pays
États-Unis
Feed Host
Site web
Flux
Demander une mise à jour
Les mises à jour peuvent prendre quelques minutes.